High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes

Atherosclerosis. 2019 Mar:282:183-187. doi: 10.1016/j.atherosclerosis.2018.07.005. Epub 2018 Jul 6.

Abstract

Background and aims: Measures of HDL function are emerging tools for assessing cardiovascular disease (CVD) event risk. HDL-apoA-I exchange (HAE) reflects HDL capacity for reverse cholesterol transport.

Methods: HAE was measured in 93 participants with type 2 diabetes (T2D) and at least one additional CVD risk factor in the Asker and Bærum Cardiovascular Diabetes study. At baseline and after seven years, the atherosclerotic burden was assessed by invasive coronary angiography. Major CVD events were registered throughout the study.

Results: Linear regression analysis demonstrated a significant inverse association between HAE and atherosclerotic burden. Cox proportional hazard regression analysis showed a significant association between HAE and a composite of major CVD events when controlling for waist-hip ratio, HR = 0.89, 95% CI = 0.80-1.00 and p=0.040.

Conclusions: Despite the relatively small size of the study population and the limited number of CVD events, these findings suggest that HAE provides valuable information in determining CVD risk.

Keywords: Cardiovascular disease; HDL; HDL function; Mortality; Type 2 diabetes.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apolipoprotein A-I / metabolism
  • Atherosclerosis / blood*
  • Atherosclerosis / complications
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / complications
  • Coronary Angiography
  • Diabetes Complications / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Female
  • Humans
  • Linear Models
  • Lipoproteins, HDL / blood*
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Regression Analysis
  • Risk Factors
  • Treatment Outcome

Substances

  • APOA1 protein, human
  • Apolipoprotein A-I
  • Lipoproteins, HDL